Archives: news

Agtech Global International Inc. and KRTL Biotech Inc. of Lakewood Colorado are pleased to jointly announce that they have signed a Memorandum of Understanding to develop and distribute new CBD and Psilocybin compounds and ultimately unique medicines under development by KRTL’s team of US and Korean medical doctors and research scientists, for the treatment of a range of debilitating human disorders.

Nova Mentis Life Science Corp. is pleased to announce it has received orphan drug designation from the European Medicines Agency for its propriety psilocybin drug for the treatment of fragile X syndrome, the leading genetic cause of symptoms related to autism spectrum disorder.

Dr. Bronner’s is pushing for psilocybin reform once again. According to state filings, Washington D.C.-based New Approach PAC, a lobbyist group, funded $14,000 between August and September to local firm Grossman Solutions to promote drug policy reform in Connecticut. Dr. Bronner’s is among New Approach’s biggest donors.

After a 25 year military career, including two tours of Afghanistan, the former master corporal struggled with post-traumatic stress disorder, depression, anxiety and chronic pain until he went through six sessions of ketamine therapy at one of Field Trip’s clinics.

Pervasip Corp. is pleased to announce that KRTL has signed a memorandum of understanding with Agtech Global International Inc. to join its race to develop compounds and ultimately novel medicines using psilocybin and other naturally occurring medicines.

Mind Medicine, a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that Chief Medical Officer Daniel R Karlin, MD MA, will chair The Digital Biomarkers & Digital Measurements Summit, held virtually on October 26 – 27, 2021.

Beckley Psytech announced that the first cohort of volunteers has been dosed in a clinical trial exploring the safety of their novel formulation of intranasal 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT).

The use of Kratom has increased in Thailand. Many kratom-infused drinks have been circling around the country.

The clinical-stage psychedelics biotech company PharmaTher has entered into an agreement with global pharmaceutical contract development and manufacturing organization (CDMO) Alcami for the clinical and commercial manufacturing of its proprietary ketamine products.

Small Pharma Inc., a neuropharmaceutical company focused on psychedelic-assisted therapies, today announced that it has received European patent grant number EP 3 463 323 as acceptance for its European patent application No. 17 728640.8.